Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Schrodinger Inc (SDGR)

  • Business News
  • June 27, 2025, 12:00 UTC
  • 1

Schrödinger, Inc. - Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/RefractoryWaldenström Macroglobulinemia

Market reaction Comment Full text

Autonomix Medical Inc. (AMIX)

  • Business News
  • June 27, 2025, 12:00 UTC
  • 1

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Market reaction Comment Full text

CorMedix Inc. (CRMD)

  • Business News
  • June 27, 2025, 12:00 UTC
  • 1

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Market reaction Comment Full text

Schrodinger Inc (SDGR)

  • Business News
  • June 27, 2025, 12:00 UTC
  • 1

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Market reaction Comment Full text

Calidi Biotherapeutics Inc (CLDI)

  • Business News
  • June 27, 2025, 12:00 UTC
  • 0

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Market reaction Comment Full text

HCW Biologics Inc. (HCWB)

  • Business News
  • June 27, 2025, 11:47 UTC
  • 0

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • June 27, 2025, 11:38 UTC
  • 0

UTHR: Notification

Market reaction Comment Full text

Danaher Corporation (DHR)

  • Business News
  • June 27, 2025, 11:35 UTC
  • 0

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

Market reaction Comment Full text

XOMA Corporation (XOMAO)

  • Business News
  • June 27, 2025, 11:30 UTC
  • 0

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

Market reaction Comment Full text

XOMA Corporation (XOMA)

  • Business News
  • June 27, 2025, 11:30 UTC
  • 0

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

Market reaction Comment Full text
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

Search

News categories

  • Technical Exchange News(9417)
  • Event(407)
  • SEC News(154535)
  • FDA Approval(8863)
  • Company Report(721)
  • Business News(105219)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin